Oculis Holding AG (OCS) Assets Average (2023 - 2026)
Oculis Holding AG (OCS) recorded quarterly Assets Average of $303.4 million in Q1 2026, up 20.15% quarter-over-quarter from $252.5 million in Q4 2025, and up 66.49% on a YoY basis from $182.2 million in Q1 2025.
Oculis Holding AG (OCS) Assets Average (2023 - 2026) Analysis & Trends
Oculis Holding AG's Assets Average history runs 4 years deep, the most recent figure standing at $303.4 million for Q1 2026.
- In Q1 2026, Assets Average rose 66.49% year-over-year to $303.4 million; the TTM figure through Mar 2026 stood at $303.4 million (up 66.49% YoY), while the FY2025 annual figure was $216.3 million, up 62.45% from the prior year.
- Assets Average was $303.4 million for Q1 2026 at Oculis Holding AG, up from $252.5 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $303.4 million in Q1 2026 to a low of $121.0 million in Q1 2024.
- Historically, Assets Average has averaged $182.4 million across 4 years, with a median of $149.2 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Assets Average climbed 0.82% in 2024, then surged 78.86% in 2025.
- A 4-year view of Assets Average shows it stood at $137.4 million in 2023, then advanced by 2.72% to $141.2 million in 2024, then soared by 78.86% to $252.5 million in 2025, then climbed by 20.15% to $303.4 million in 2026.
- The last three Assets Average figures came in at $303.4 million (Q1 2026), $252.5 million (Q4 2025), and $214.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 40.89 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 26.03 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 660.38 Mn |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - | 303.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 303.40 Mn |
| Dec 31, 2025 | 252.52 Mn |
| Sep 30, 2025 | 214.60 Mn |
| Jun 30, 2025 | 223.23 Mn |
| Mar 31, 2025 | 182.24 Mn |
| Dec 31, 2024 | 141.18 Mn |
| Sep 30, 2024 | 149.19 Mn |
| Jun 30, 2024 | 133.25 Mn |
| Mar 31, 2024 | 121.01 Mn |
| Dec 31, 2023 | 137.45 Mn |
| Sep 30, 2023 | 147.98 Mn |